Literature DB >> 12578557

Novel insights into how purines regulate pituitary cell function.

D Aled Rees1, Maurice F Scanlon, Jack Ham.   

Abstract

Purine nucleosides and nucleotides are widely distributed substances that exhibit a diverse range of effects in a number of tissues, acting as important extracellular signalling molecules in addition to their more established roles in cellular metabolism. They mediate their effects via activation of distinct cell surface receptors, termed adenosine (or P1) and P2 purinergic receptors. Although roles for adenosine and adenine nucleotides have been described previously in the pituitary gland, the distribution of the receptor subtypes and the effects of their activation on pituitary function are not well defined. Recent evidence, however, has emerged to describe a complex signalling system for purines in the pituitary gland. Data from a variety of studies have shown that the expression pattern, number and affinity of adenosine and/or P2 receptors may be cell-type specific and that non-endocrine in addition to endocrine cells elaborate these receptors. These variations, along with the diverse range of signalling pathways activated, dictate the response of individual cell types to extracellular purines, with roles now emerging for these substances in the regulation of hormone release, pituitary cell proliferation and cytokine/growth factor expression. In this review, we discuss these advances and examine some implications for pituitary growth control and the response of the hypothalamic-pituitary-adrenal axis to stress and inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578557     DOI: 10.1042/CS20030053

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

2.  Characterization of purinergic P2X4 receptor channels expressed in anterior pituitary cells.

Authors:  Hana Zemkova; Marek Kucka; Shuo Li; Arturo E Gonzalez-Iglesias; Melanija Tomic; Stanko S Stojilkovic
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

Review 3.  Purinergic signaling pathways in endocrine system.

Authors:  Ivana Bjelobaba; Marija M Janjic; Stanko S Stojilkovic
Journal:  Auton Neurosci       Date:  2015-04-25       Impact factor: 3.145

Review 4.  Neurotransmitter receptors as signaling platforms in anterior pituitary cells.

Authors:  Hana Zemková; Stanko S Stojilkovic
Journal:  Mol Cell Endocrinol       Date:  2017-07-03       Impact factor: 4.102

Review 5.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

6.  Intestinal ischemia-reperfusion injury alters purinergic receptor expression in clinically relevant extraintestinal organs.

Authors:  Peter M Milano; Christelle D Douillet; Paul J Riesenman; William P Robinson; Stephanie K Beidler; Ben L Zarzaur; Preston B Rich
Journal:  J Surg Res       Date:  2007-08-03       Impact factor: 2.192

Review 7.  Purinergic regulation of hypothalamopituitary functions.

Authors:  Stanko S Stojilkovic
Journal:  Trends Endocrinol Metab       Date:  2009-10-01       Impact factor: 12.015

Review 8.  Signaling by purinergic receptors and channels in the pituitary gland.

Authors:  Stanko S Stojilkovic; Mu-Lan He; Taka-aki Koshimizu; Ales Balik; Hana Zemkova
Journal:  Mol Cell Endocrinol       Date:  2009-05-23       Impact factor: 4.102

9.  Release and extracellular metabolism of ATP by ecto-nucleotidase eNTPDase 1-3 in hypothalamic and pituitary cells.

Authors:  Mu-Lan He; Arturo E Gonzalez-Iglesias; Melanija Tomic; Stanko S Stojilkovic
Journal:  Purinergic Signal       Date:  2005-03-07       Impact factor: 3.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.